Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Evolent Health ( (EVH) ) just unveiled an announcement.
Evolent Health, Inc. announced the retirement of Ms. Cheryl Scott from its Board of Directors on December 1, 2025, and the appointment of Ms. Jill Smith as her successor. Ms. Smith, an experienced business leader with a strong background in technology and executive roles, will serve until the company’s 2026 Annual Meeting. The company also reaffirmed its fourth quarter 2025 revenue and Adjusted EBITDA guidance, maintaining its previous estimates despite the challenges in reconciling non-GAAP measures to net income due to various adjustments.
The most recent analyst rating on (EVH) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Evolent Health stock, see the EVH Stock Forecast page.
Spark’s Take on EVH Stock
According to Spark, TipRanks’ AI Analyst, EVH is a Neutral.
Evolent Health’s overall stock score is primarily impacted by its weak financial performance and technical indicators, which suggest bearish momentum and financial instability. Despite positive earnings call highlights and future growth prospects, the current financial and valuation challenges weigh heavily on the stock’s attractiveness.
To see Spark’s full report on EVH stock, click here.
More about Evolent Health
Average Trading Volume: 3,542,576
Technical Sentiment Signal: Sell
Current Market Cap: $446.4M
For an in-depth examination of EVH stock, go to TipRanks’ Overview page.